Last reviewed · How we verify
NCT05813977
Amount of Droplet Formed During Percutaneous Dilatational Tracheostomy
NA trial testing tritube in Ventilatory Failure in 39 participants. Completed in 14 September 2023.
14 September 2023
Quick facts
| Lead sponsor | Ankara Diskapi Training and Research Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | prevention |
| Enrollment | 39 |
| Start date | 11 April 2023 |
| Primary completion | 14 September 2023 |
| Estimated completion | 14 September 2023 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- tritube
Conditions studied
- Ventilatory Failure — all drugs for Ventilatory Failure →
Sponsor
Ankara Diskapi Training and Research Hospital
Who can join
Adults 18 to 90, any sex, with Ventilatory Failure. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
During the percutaneous dilatational tracheostomy (PDT), large amount of droplets and aerosols are spread to the environment especially with the effect of ventilation during the dilatation phase. In such cases, it is recommended to take precautions such as masks and goggles or shields to protect practitioners from infection, however it has also been reported that droplets and aerosols can spread to the environment and can go far. Flow controlled ventilation (FCV) with the use of Tritube® and Evone® could reduce droplet spread during PDT and provide a safer environment while operating on patients with infected airways.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05813977
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Ventilatory Failure
Currently open trials in the same condition.
- NCT05861323 — Feasibility of the Comfort Measures Only Time Out (CMOT) · NA · active not recruiting
- NCT04484727 — "Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs" · recruiting
Other Ankara Diskapi Training and Research Hospital trials
Trials by the same sponsor.
- NCT07114965 — Effects Of Quadratus Lumborum Type 1 Block And Transversalis Facial Plane Block On Acute Pain In Gynecological Surgery · active not recruiting
- NCT05945706 — Evaluation of Renal Resistive Index in Patients with Controlled Hypotension · completed
- NCT05409690 — Renal Arterial Resistive Index for Differential Diagnosis of Acute Kidney Injury · unknown
- NCT05339828 — Unroofing Curettage for Pilonidal Disease · completed
- NCT05303441 — The Predictive and Diagnostic Value of Cystatin C and High Sensitive Troponin · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05813977 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Ankara Diskapi Training and Research Hospital
- Last refreshed: 9 July 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05813977.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing